Hydrochloric Acid

Hydrochloric Acid

SCHEMBL7954846

Cl.N#Cc1ccc2[nH]cc(CCCCN3CCN(c4ccc(F)cc4)CC3)c2c1

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
HTR1A known ✓ P08908 5/20 0.75
DRD2 known ✓ P14416 1/20 0.74
DRD4 known ✓ P21917 1/20 0.74
DRD3 known ✓ P35462 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7530566 0.99 HTR1A (0.76) HTR1ADRD2DRD4DRD3
SCHEMBL7954823 0.95 HTR1A (0.72) HTR1ADRD2DRD4DRD3
Hydrochloric Acid SCHEMBL4426960 0.94 HTR1A (0.77) HTR1A
SCHEMBL4416131 0.93 HTR1A (0.79) HTR1A
SCHEMBL27528081 0.92 HTR1A (0.70) HTR1A
SCHEMBL9258263 0.90 HTR1A (0.70) HTR1A
SCHEMBL7956463 0.90 HTR1A (0.77) HTR1A
SCHEMBL9696788 0.89 HTR1A (0.79) HTR1A
SCHEMBL8544143 0.89 HTR1A (0.73) HTR1A
SCHEMBL8542180 0.89 HTR1A (0.78) HTR1ADRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310068-B1 3-(4-(4-(4-CYANOPHENYL)-1-PIPERAZINYL)BUTYL)-5-CYANOINDOLE; 3-(4-(4-(4-FLUOROPHENYL)-1-PIPERAZINYL)BUTYL)-5-CYANOINDOLE, BOTH IN FORM OF HYDROCHLORIDE SALT; TREATING DEPRESSION, PARKINSON'S DISEASE, ISCHEMIA MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2001-10-30 US claimed
CN-1072209-C Benzonitriles and benzofluorides MERCK PATENT GMBH (DE) 2001-10-03 CN claimed
CN-1137036-A Benzonitriles and benzofluorides MERCK PATENT GMBH (DE) 1996-12-04 CN claimed
EP-0736525-A1 Benzonitriles and -fluorides as 5-HT agonists and antagonists MERCK PATENT GmbH (DE) 1996-10-09 EP claimed
US-6310068-B1 3-(4-(4-(4-CYANOPHENYL)-1-PIPERAZINYL)BUTYL)-5-CYANOINDOLE; 3-(4-(4-(4-FLUOROPHENYL)-1-PIPERAZINYL)BUTYL)-5-CYANOINDOLE, BOTH IN FORM OF HYDROCHLORIDE SALT; TREATING DEPRESSION, PARKINSON'S DISEASE, ISCHEMIA MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2001-10-30 US disclosed
CN-1072209-C Benzonitriles and benzofluorides MERCK PATENT GMBH (DE) 2001-10-03 CN disclosed
CN-1137036-A Benzonitriles and benzofluorides MERCK PATENT GMBH (DE) 1996-12-04 CN disclosed
EP-0736525-A1 Benzonitriles and -fluorides as 5-HT agonists and antagonists MERCK PATENT GmbH (DE) 1996-10-09 EP disclosed